Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

New software supporting sleep testing device (Brizzy) now available on mHealthBelgium

On May 4, 2020, a new web platform called Brizzy entered the level 1 of the mHealthBelgium validation pyramid. Brizzy is a CE-marked (class IIa) sleep testing device allows diagnosing respiratory sleep disorders efficiently and accurately and avoids the complexity and discomfort associated with traditional systems.

The device measures the mandibular movements (JawAc), the position of the body, and optionally either the heart rate or blood oxygen. The collected data are transferred to the secure manufacturer’s server for analysis. The physician or healthcare professional is notified by email that a report is available

It is approved for both adults and children.

Regarding pricing, the SAAS (Software as a service) model payment is used. The company charges €30 (excl. VAT) per analysis performed on the platform. The price of the Brizzy recorder device is €419.

See the full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.